Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis (MS)

Update Item Information
Identifier 20120214_nanos_posters_091
Title Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis (MS)
Creator Marco Zarbin; Anthony T. Reder; William Collins; Gordon Francis; Xiaoli Zhang; Ludwig Kappos; Jeffrey A. Cohen
Affiliation (MZ) (JAC) Institute of Ophthalmology and Visual Science-New Jersey Medical School, NJ; (ATR) Department of Neurology MC-2030, University of Chicago, IL; (WC) Novartis Pharma AG, Basel, Switzerland; (GF) (XZ) Novartis Pharmaceuticals Corporation, NJ; (LK) Departments of Neurology and Biomedicine, University Hospital, Basel, Switzerland; Neurological Institute, Cleveland Clinic Foundation, OH
Subject Multiple Sclerosis; Fingolimod; Ophthalmic Evaluation
Description Fingolimod is a sphingosine 1-phosphate receptor modulator used to treat relapsing MS. The results of ophthalmic evaluations during clinical studies of fingolimod in patients with MS are reported.
Date 2012-02-14
Language eng
Format application/pdf
Type Text
Source 2012 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2012: Poster Presentations
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2012. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6m07bzf
Setname ehsl_novel_nam
ID 181851
Reference URL https://collections.lib.utah.edu/ark:/87278/s6m07bzf